| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.08B | 2.58B | 2.30B | 3.28B | 2.97B |
| Gross Profit | 75.95M | 135.24M | 130.95M | 732.08M | 739.34M |
| EBITDA | 260.07M | 357.43M | 348.52M | 866.03M | 850.32M |
| Net Income | 58.26M | 131.70M | 109.38M | 701.86M | 844.81M |
Balance Sheet | |||||
| Total Assets | 2.28B | 2.41B | 2.43B | 2.65B | 2.75B |
| Cash, Cash Equivalents and Short-Term Investments | 270.52M | 282.04M | 261.40M | 443.82M | 459.67M |
| Total Debt | 230.39M | 344.36M | 366.25M | 471.90M | 648.59M |
| Total Liabilities | 453.39M | 587.39M | 634.53M | 741.33M | 914.21M |
| Stockholders Equity | 1.82B | 1.83B | 1.80B | 1.91B | 1.83B |
Cash Flow | |||||
| Free Cash Flow | 148.10M | 180.93M | 101.33M | 850.60M | 625.94M |
| Operating Cash Flow | 264.69M | 309.33M | 353.40M | 935.32M | 850.42M |
| Investing Cash Flow | -54.51M | -87.40M | -61.17M | 63.18M | -334.00M |
| Financing Cash Flow | -230.61M | -214.40M | -389.73M | -949.13M | -433.03M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | HK$84.78B | 7.76 | 48.55% | 9.80% | 11.50% | 17.54% | |
78 Outperform | HK$9.51B | 11.77 | 9.59% | 8.83% | 2.17% | 8.72% | |
65 Neutral | HK$244.79B | 6.39 | 13.13% | 12.48% | -6.12% | -35.50% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | HK$15.44B | 26.23 | 2.51% | 2.88% | -19.46% | -55.11% | |
53 Neutral | HK$349.99M | 12.38 | 5.31% | ― | -0.89% | -50.76% | |
47 Neutral | HK$33.35B | 14.39 | 5.24% | 4.16% | -8.82% | 11.45% |